<DOC>
	<DOCNO>NCT02161562</DOCNO>
	<brief_summary>This trial ass efficacy optimize re-treatment therapy omalizumab ( 150mg 300mg ) relapse , patient Chronic Spontaneous Urticaria clinically well-controlled follow first course treatment omalizumab ( 150mg 300mg ) . Will also assess benefit uptitrating 300mg dose patient well-controlled follow first course treatment omalizumab 150mg .</brief_summary>
	<brief_title>OPTIMA : Efficacy Optimized Re-treatment Step-up Therapy With Omalizumab Chronic Spontaneous Urticaria ( CSU ) Patients</brief_title>
	<detailed_description />
	<mesh_term>Urticaria</mesh_term>
	<mesh_term>Omalizumab</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<criteria>Men woman least 18 year age time screen . Having diagnosis CSU presence symptom ≥6 month prior screen visit . Presence itch hive ≥6 consecutive week time prior screen visit despite concurrent use nonsedating H1antihistamine treatment Patient must approve dose nonsedating H1antihistamine CSU , concomitant CSU treatment , least 7 consecutive day immediately prior randomization visit must document current use day randomization visit . Patients clearly define underlying etiology chronic urticaria CSU include follow urticarias : acute , solar , cholinergic , heat , cold , aquagenic , delayed pressure contact Patients skin disease associate itch could interfere study outcome and/or compromise safety patient Patients evidence parasitic infection Patients history malignancy organ system ( localize basal cell carcinoma skin ) , treat untreated , within past 5 year , regardless whether evidence local recurrence metastasis . Pregnant nursing ( lactate ) woman , Women childbearing potential , unless use effective method contraception dose study treatment . Patients unable unwilling comply study procedure , attend schedule study visit , complete questionnaire daily diary , may otherwise unable comply study requirement . Other eligibility criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>chronic spontaneous urticaria , CSU , chronic idiopathic urticaria , CIU , hive , angioedema , itch</keyword>
</DOC>